Published: December 3rd 2024 | Updated: December 6th 2024
ASH 2024 Preview for Community Oncologists: The Show and After Show
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab Across Various Solid Tumors
Published: February 3rd 2025 | Updated: April 28th 2025
ENVISION Trial of UGN-102 Shows Durable Responses in LG-IR-NMIBC
Published: April 26th 2025 | Updated: April 28th 2025
Predicting Cretostimogene Grenadenorepvec Response With Urinary Genomics
Published: January 6th 2023 | Updated: April 28th 2025
Bridging Options for CAR T-Cell Therapy in R/R DLBCL
Published: April 23rd 2025 | Updated: April 28th 2025
Challenges Facing Clinicians and Community Oncology Practices